Abstract:OBJECTIVES(1) To investigate the levels of the serum soluble endothelial growth factor receptor-1 in women with preeclampsia and compare the difference between the groups of the mild preeclampsia, severe preeclampsia and eclampsia. For more, to analyze the relativity between the levels of the serum soluble vascular growth factor receptor-1 and preeclampsia. (2) To detect the expression of the membrane-bound VEGFR-1 protein in the placenta tissue of the women with preeclampsia and compare the difference between the groups of the mild preeclampsia, severe preeclampsia and eclampsia, Then to analyze the relativity between the expression of the membrane-bound endothelial growth factor receptor-1 and preeclampsia.METHODS(1) The serum levels of sVEGFR-1 in 10 women with mild preeclampsia, 10 women with severe preeclampsia, 10 women with eclampsia, 10 women without preeclampsia were detected by the quantitative sandwich enzyme immunoassay technique. (2) Immunohistochemistry and quantitative analysis were used to detect membrane-bound VEGFR-1 contents and distribution in the placenta tissue.RESULTS(1) The results showed that the serum sVEGFR-1 levels of all preeclampsia groups were relatively higher than those of control group (P < 0.05) and that there were significant differences between the groups of the mild preeclampsia, severe preeclampsia and eclampsia. (2) In placentas, the positive staining was detected predominantly in the membranes of villus syncytiotrophoblast cells, extravillous trophoblast cells, and villus endothelial cells. In fetal membranes, the positive staining was detected predominantly in amnionic endothelial cells. (3) The contents of membrane-bound VEGFR-1 in placenta of preeclampsia groups were relatively lower than that of control group. There were significant differences between membrane-bound VEGFR-1 contents of the mild preeclampsia,severe preeclampsia and eclampsia (P < 0.05). (4) The ratio of the sVEGFR-1 concentration in serum and the membrane-bound VEGFR-1 contents in placenta of preeclampsia groups (sVEGFR-1/ membrane-bound VEGFR-1) was relatively higher than that of control group (P < 0.05) and there were significant differences between the groups of the mild preeclampsia, severe preeclampsia and eclampsia (P < 0.05).CONCLUSIONS(1) The serum sVEGFR-1 levels of preeclampsia groups were relatively higher than those of control group, the VEGFR-1 may be related to preeclampsia. (2) The contents of membrane-bound VEGFR-1 in placenta of preeclampsia groups were relatively lower than that of control group, the membrane-bound VEGFR-1 may relate to preeclampsia. (3) The ratio of the sVEGFR-1 concentration in serum and the membrane-bound VEGFR-1 contents in placenta of preeclampsia groups (sVEGFR-1/membrane-bound VEGFR-1) was relatively higher than that of control group, the preeclampsia may contribute to VEGFR-1/ PLGF and sVEGFR-1/membrane-bound.

The expression of CXCL12 and VEGF in preeclampsia

Progress in Soluble Vascular Endothelial Growth Factor Receptor-1 and Preeclampsia

The expressions and significances of VEGF and p53 in placenta of normal pregnancy and pre-eclampsia patients

Association of a Reduction of G-protein Coupled Receptor 30 Expression and the Pathogenesis of Preeclampsia

Serum and Placental Interleukin-18 Are Elevated in Preeclampsia

Expression and clinical implication of endothelial glycoprotein,vascular endothelial growth factor and its receptor 1 in preeclampsia

Effect of Vascular Endothelial Growth Factor on Pre-Eclampsia in Pregnant Rats

EXPRESSION OF ENDOTHELIN-1 GENE IN THE VILLUS OF PRE-ECLAMPSIA

Elevated Serum Levels of Interleukin-15 and Interleukin-16 in Preeclampsia.

Expression and significance of a disintegrin and metalloproteinase 12 in placenta of preeclampsia

[Expression of Fas and FasL in Serum and Placenta of Preeclamptic Pregnancy and Its Significance].

[Relationship Between Serum and Placental Interleukin-18 Levels and Preeclampsia].

[Vasohibin and VEGF Protein Levels in Placentae from Pregnancies Complicated by Severe Pre-Eclampsia].

Inconformity of CXCL3 Plasma Level and Placenta Expression in Preeclampsia and Its Effect on Trophoblast Viability and Invasion

Expression of Placental Vascular Growth Factor in Pregnancy-Induced Hypertension

Expressions of survivin protein and survivin mRNA in placenta with pre-eclampsia

[VCAM-1 and E-selectin Expression in Extravillous Cytotrophoblasts of Severe Preeclampsia].

The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients

[The Relativity of Vascular Endothelium Growth Factor Receptor-1 and Preeclampsia].

Relationship of Hypoxia-inducible Factor-1αand Endoglin Expression in Placenta and Soluble Endoglin in Serum in Preeclampsia

Effect of Pre-eclampsia Serum on Cytotrophoblast Invasive Ability and Endothelial Cell Apoptosis in a Model of Cytotrophoblast Coculture with Endothelial Cell